In continuation to the press release and disclosure submitted under Regulation 30 on Feb 7, 2025, we wish to clarify that inadvertently in Ms. Namita Thapar''s profile, it was mentioned that she is the executive Director and CEO of India Business of Emcure Pharmaceuticals Limited. Please note that she is the whole-time director of Emcure Pharmaceuticals Limited and heading its India business.